About Algorithm Sciences
Algorithm Sciences is a private company based in New York, New York, incorporated in 2019 in Delaware. It has reported $7,157,131 raised in five offerings on Form D since October 2019. Its chief executive is Michael Tilton.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 9, 2024 | Apr 12, 2024 | $350,000of $23.5M target | 2 | $175K | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| May 3, 2022 | Apr 7, 2023 | $684,651of $5.0M target | 35 | $19,561 | Equity, Series C Preferred StockRule 506(b) | Form D ↗ |
| Dec 13, 2021 | Dec 28, 2021 | $1,135,000of $7.0M target | 10 | $113K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 12, 2021 | Mar 26, 2021 | $2,899,500of $10.0M target | 39 | $74,346 | Equity, Series B Preferred StockRule 506(b) | Form D ↗ |
| Oct 10, 2019 | Oct 23, 2019 | $2,087,980of $6.0M target | 23 | $90,782 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $7,157,131 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Algorithm Sciences's Form D filed Apr 12, 2024.
MT
Michael Tilton
Chief Executive Officer and director
DC
David Cavalier
Chief Financial Officer and Chief Operating Officer
KM
Kamal Mubark
Director
JA
MD
Matthew Duffy
Director
Also a director at Aerwave Medical, a president, treasurer, secretary and director at PD Theranostics and a president and director at Voltron Therapeutics.
JD
AZ
GG
Gary Gemignani
Director
PG
Patrick Gallagher
Director
Also a director at Aerwave Medical and a chief executive officer and director at PD Theranostics and Voltron Therapeutics.
Earlier filings also listed Kamal Mubarak (president, chief scientific officer and director, last listed Dec 2021) and Gary Gemigani (director, last listed Dec 2021).